Artivion (AORT) Acquisitions (2012 - 2020)

Artivion's (AORT) quarterly Acquisitions came in at -$524000.0 in Q4 2020, up 99.42% on a QoQ basis from -$89.9 million in Q3 2016.

Artivion (AORT) Acquisitions (2012 - 2020) Analysis & Trends

Artivion (AORT) has 3 years of Acquisitions data on file, last reported at -$524000.0 in Q4 2020.

Quarterly Acquisitions changed N/A year-over-year to -$524000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$90.4 million (changed N/A YoY) and the FY2020 annual result came in at $59.1 million, changed N/A from the prior year.
Acquisitions improved to -$524000.0 in Q4 2020, from -$89.9 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $91.2 million in Q1 2016 to a low of -$89.9 million in Q3 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	-
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	437.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-4.00 Mn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-3.49 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	16.00 Mn
10	Artivion	1.36 Bn	1.28 Bn	80.52 Mn	-

Download Data